Potentials of Sludge from Drinking Water Treatment Plant for Use as Source of Soil Nutrients for Reclamation of Degraded Land

The residuals from Gubi drinking water treatment plant are usually discharged directly into the nearby streams without any form of treatment. The decomposition of the organic materials contained in the untreated sludge has caused the production of malodorous gases and unsightly condition in the area. The disposal of this sludge in an environmentally friendly manner is therefore not only desirable but necessary. The aim of this investigation was to assess the feasibility of utilizing the residuals from Gubi water treatment plant as a source of nutrients for reclamation of degraded lands especially those arising from mining activities. The study was carried out at Gubi water treatment plant located in the vicinity of Gubi Dam water reservoir.Ten sludge samples were collected from each of the three clerifiers. Important sludge properties that are known to aid nutrients status of soil were analyzed using standard laboratory procedures. The means of various soil quality parameters recorded in the WTRs were 6.8, 20.06g/kg, 34.90g/kg, 1.65g/kg, 2.30g/kg, 13.45mg/kg, 2.50Cmol/kg, 2.10Cmol/kg and 28Cmol/kg for pH, Organic C, Organic Matter, K, Total N, Olsen P, Ca, Mg and CEC respectively. The means of all the parameters analysed falls within the ranges considered good for vegetation growth. The heavy metals concentrations recorded in the residual were 1.8mg/kg, 0.1mg/kg, 2mg/kg, 29mg/kg, 66mg/kg, 15mg/kg, 8.7mg/kg, 6.2mg/kg and 0.03mg/kg for As, Cd, Pb, Cu, Zn, Ni, Co, Cr and Hg respectively. The concentrations of all the metals did not exceed the acceptable threshold limits recommended by regulatory authorities. Considering the enormous amount of plant nutrients and absence of excessive toxic metals in Gubi WTRs, it is safe to conclude that the residual can be use as a source of soil nutrients for reclamation of degraded land. Key words: Sludge, Soil Nutrients, Degraded Land, Reclamatio

Antibiogram of pharyngeal isolates of children with pharyngotonsillitis in a specialist hospital in Gusau, North-Western Nigeria

Pharyngotonsillitis is one of the common childhood infections caused by bacteria in 30 to 40% of cases. Bacterial causes are important due to the non suppurative sequalae caused by Streptococcus pyogenes and also associated complications. These microorganisms undergo constant changes and antibiotic resistance have been reported. Objective: To document organisms isolated from throat swab microscopy and culture with their antibiotic susceptibility pattern in children diagnosed with pharyngotonsillitis. Methodology: This was a retrospective analysis of throat swabs microscopy, culture and sensitivity results of children aged 0-13 years with a diagnosis of pharyngotonsillitis over a four-year period. Results: Of the 144 results reviewed; 120 samples yielded 122 isolates, giving a culture positive yield of 83.3%. Males were 81 (56.2%) with a M:F ratio of 1.3:1. Majority of the children were under fives (58.3%). Gram positive organisms were 118 (96.7%), with Streptococcus pyogenes being the commonest organism isolated (79.5%), followed by Staphylococcus aureus (13.9%). Gentamicin (85.0%), Ofloxacin (64.2%) and Augmentin (51.7%) had the highest susceptibility rate, while the least was seen with Cefixime, Tetracycline, Levofloxacin and Netillin. Streptococcus pyogenes and Staphylococcus aureuswere susceptible to Gentamicin and Ofloxacin, while all the Streptococcus pneumoniae were susceptible to Gentamicin. Multi drug resistance was seen with Providencia spp and Serratia marcescens. Conclusion: Streptococcus pyogenes was the commonest organism and Gentamicin, Ofloxacin and Augmentin were the antibiotics with the highest susceptibility. Gram negative organisms display high rate of multidrug resistance. Gentamicin could be considered as an option or an adjunct in the treatment of pharyngotonsilliti

Phytochemical analysis, analgesic and antipyretic properties of ethanolic leaf extract of Vernonia amygdalina Del.

Introduction: Vernonia amygdalina Del. has been traditionally used in relieving pain and inflammatory conditions as well as in treatment of feverish conditions by local people of the North-east Nigeria. Consequently this study aims at evaluating the phytochemical content, antipyretic and analgesic properties of V. amygdalina (biter leaf).Methods: The leaf of V. amygdalina was soxhlet extracted with ethanol and sequentially partitioned using solvent of different polarities. Phytochemical test was conducted to ascertain the secondary metabolites present in the extract using standard procedures. Acute toxicity (LD50) of the extract on laboratory rats was estimated by following protocols of Lorke. The antinociceptive activity of the ethanolic extract was also evaluated using acetic acid induced pain and hot plate method.Results: The results revealed the presence of tannins, phlobatannins, saponins, carbohydrates, cardioactive glycoside, flavonoids, alkaloids, steroids and terpenes. Anthraquinones were absent in the extract. The intraperitoneal LD50 was found to be 3721 mg/kg. On administration of 5000 mg/kg dose of the extract via oral route, there was no dead. The extract demonstrated significant antinociceptive activities as 36.0 ± 0.81, 43.8 ± 0.11 and 52.8±0.37 (Mean number of writhings) respectively for the doses 600, 400 and 200 mg/kg i.p.) as compared to the control (60.0 ± 0.11). High dose of 400 mg/kg significantly reduced rectal temperature (P < 0.05)Conclusion: These results demonstrated the medicinal potentiality of V. amygdalina and might be used as analgesic, and antipyretic agent. Phytochemicals found in such as flavonoids, tannins, alkaloids and steroids seem to be implicated in having such pharmacological activities

Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium

© 2015 Webster et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. The attached file is the published version of the article

Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium

© Webster et al. 2015. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated

Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium

© Webster et al. 2015. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Market‐led options to scale up legume seeds in developing countries: Experiences from the Tropical Legumes Project

There are several hurdles to ensure sustainable seed production and consistent flow of improved legume varieties in sub‐Saharan Africa (SSA) and South Asia (SA). The unreliable demand, autogamous nature of most of the grain legumes, and slow variety replacement rate by smallholder farmers do not provide strong incentive for private seed companies to invest in legume seed business. Unless a well thought‐out and comprehensive approach to legume seed delivery is developed, current seed shortages will continue, eroding emerging market opportunities. The experiences reported here are collated through a 10‐year partnership project, the Tropical Legumes in SSA and SA. It fostered innovative public–private partnerships in joint testing of innovative market‐led seed systems, skills and knowledge enhancement, de‐risking private sector initiatives that introduced in new approaches and previously overlooked entities in technology delivery. As new public and private seed companies, individual seed entrepreneurs and farmer organizations emerged, the existing ones enhanced their capacities. This resulted in significant rise in production, availability and accessibility of various seed grades of newly improved and farmer demanded legume varieties in the target countries

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication